creating a
healthier future

DONATE NOW SUPPORT SCIENCE

News

26.06.26

i3S discovers treatment that enhances chemotherapy against acute myeloid leukaemia

New therapeutic strategy that enhances chemotherapy against acute myeloid leukaemia to be tested in collaboration with IPO Porto.

26.06.25

i3S launches national survey on genetic screening before pregnancy

The project aims to understand the views of people living in Portugal on preconception genetic carrier screening and support the development of a genetic counselling programme tailored to the national context.

26.06.15

Ana Paula Pêgo becomes the first career researcher in the Vice-Rectorate of the University of Porto

i3S scientist to lead the Research and Knowledge Valorisation portfolio

26.06.15

i3S discovers a “hidden” function of DNA associated with a neurodegenerative disease

Spinocerebellar ataxia type 37 is a rare genetic neurodegenerative disorder, the symptoms of which resemble those of Machado-Joseph disease.

26.06.05

Researcher Wins University of Porto 3MT with Neurosciences Project

Rafaela Seixas won 1st place in the 2026 edition of the Three Minute Thesis (3MT) with a presentation on astrocytic heterogeneity.

26.06.05

i3S Researcher Awarded for Work in Bone and Mineral Research

Sara Moura studies the role of non-coding RNAs to better understand pathologies associated with bone loss.

26.06.05

Researcher Receives Fellowship to Present Research in Sweden

Carolina Pereira’s work focuses on acute myeloid leukaemia and resistance to chemotherapy treatments.

26.06.05

i3S Project Receives Funding to Develop AI that Learns to Communicate with Neurons

The objective is to create new artificial intelligence tools for future brain stimulation therapies.

26.06.05

University of Porto Doctor Wins Two Fellowships to Study Early-Onset Colorectal Cancer

Henrique Fernandes-Mendes’s research receives 16 thousand euros in funding awarded by two distinct scientific societies.

Subscribe to our newsletter and keep up to date with our latest achievements.

Newsletter Subscription

Contacts
Status & Reports
Privacy Policy
Cookie Policy
Terms & Conditions
Whistleblower Channel